Terrence A. Duffy - 15 Sep 2026 Form 4 Insider Report for CME GROUP INC. (CME)

Reporting relationship: Chairman and CEO, Director
Issuer ticker: CME
Reported as of: 15 Sep 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 17 Sep 2026, 16:21:12 UTC
Prior SEC filing: 11 Sep 2026
Source filing: View source filing
Reporting owner signature: /s/ Elizabeth Hensen, as Attorney-in-Fact for Terrence A. Duffy

Key filing fact

Terrence A. Duffy filed Form 4 for CME GROUP INC. (CME) on 17 Sep 2026.

Key facts

This page summarizes Terrence A. Duffy's Form 4 filing for CME GROUP INC. (CME).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 17 Sep 2026, 16:21.

Change

Previous filing in this sequence was filed on 11 Sep 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001212809 Primary reporting owner

DUFFY TERRENCE A

Relationship: Chairman and CEO, Director
Address: 20 S. WACKER DRIVE, CHICAGO
Signature: /s/ Elizabeth Hensen, as Attorney-in-Fact for Terrence A. Duffy
Signature date: 17 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CME transaction

Common Stock Class A

Award

Transaction value
Shares: +21,812
Change %: +54%
Price: $275.09^*
Shares after: 62,442
Date: 15 Sep 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents a grant of restricted stock under the CME Group Omnibus Stock Plan, vesting in four equal annual installments, subject to continued service.